Mutations in the FPIV motif of Newcastle disease virus matrix protein attenuate virus replication and reduce virus budding

Archives of Virology

Volumn 159, Issue 7, 2014, Pages 1813-1819

  Duan, Zhiqiang ^a   Hu, Zenglei ^a   Zhu, Jie ^a   Xu, Haixu ^a   Chen, Jian ^a   Liu, Huimou ^a   Hu, Shunlin ^a   Liu, Xiufan ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Budding; Late domain; Matrix protein; Newcastle disease virus; Virus replication

Indexed keywords

MUMPS VIRUS; NEWCASTLE DISEASE VIRUS; PARAINFLUENZA VIRUS;

MATRIX PROTEIN;

ARTICLE; CHEMISTRY; GENETICS; METABOLISM; MUTATION; NEWCASTLE DISEASE PARAMYXOVIRUS; PHYSIOLOGY; PROTEIN MOTIF; VIRUS RELEASE; VIRUS REPLICATION;

AMINO ACID MOTIFS; MUTATION; NEWCASTLE DISEASE VIRUS; VIRAL MATRIX PROTEINS; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84903556422     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-014-1998-2     Document Type: Article

References (30)

1. Alexander DJ (1997) Newcastle disease and avian paramyxovirus infections. In: Calnek BW, Barnes HJ, Beard CW, McDougald LR (eds) Disease of poultry, 10th edn. Iowa State University Press, Ames, pp 541-569.
2. Bieniasz PD (2006) Late budding domains and host proteins in enveloped virus release. Virology 344: 55-63.
3. Ciancanelli MJ, Basler CF (2006) Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 80: 12070-12078.
4. Demirov DG, Orenstein JM, Freed EO (2002) The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J Virol 76: 105-117.
5. Demirov DG, Freed EO (2004) Retrovirus budding. Virus Res 106: 87-102.
6. Duan Z, Li Q, He L, Zhao G, Chen J et al (2013) Application of green fluorescent protein-labeled assay for the study of subcellular localization of Newcastle disease virus matrix protein. J Virol Methods 194: 118-122.
7. Freed EO (2002) Viral late domains. J Virol 76: 4679-4687.
8. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH et al (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65.
9. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 88: 3195-3199.
10. Harrison MS, Sakaguchi T, Schmitt AP (2010) Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 42: 1416-1429.
11. He L, Zhao G, Zhong L, Liu Q, Duan Z et al (2013) Isolation and characterization of two H5N1 influenza viruses from swine in Jiangsu Province of China. Arch Virol 158: 2531-2541.
12. Hu S, Ma H, Wu Y, Liu W, Wang X et al (2009) A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27: 904-910.
13. Hu S, Wang T, Liu Y, Meng C, Wang X et al (2010) Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 140: 92-97.
14. Huang M, Orenstein JM, Martin MA, Freed EO (1995) p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 69: 6810-6818.
15. Irie T, Shimazu Y, Yoshida T, Sakaguchi T (2007) The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol 81: 2263-2273.
16. Jayakar HR, Murti KG, Whitt MA (2000) Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74: 9818-9827.
17. Li M, Schmitt PT, Li Z, McCrory TS, He B et al (2009) Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol 83: 7261-7272.
18. Liu YL, Hu SL, Zhang YM, Sun SJ, Romer-Oberdorfer A et al (2007) Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein. Arch Virol 152: 1241-1249.
19. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD (2003) Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci USA 100: 12414-12419.
20. Negovetich NJ, Webster RG (2010) Thermostability of subpopulations of H2N3 influenza virus isolates from mallard ducks. J Virol 84: 9369-9376.
21. Pantua HD, McGinnes LW, Peeples ME, Morrison TG (2006) Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol 80: 11062-11073.
22. Patch JR, Han Z, McCarthy SE, Yan L, Wang LF et al (2008) The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol J 5: 137.
23. Perez M, Craven RC, de la Torre JC (2003) The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci USA 100: 12978-12983.
24. Pornillos O, Garrus JE, Sundquist WI (2002) Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12: 569-579.
25. Puffer BA, Parent LJ, Wills JW, Montelaro RC (1997) Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 71: 6541-6546.
26. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Epidemiol 27: 493-497.
27. Schmitt AP, Lamb RA (2004) Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol 283: 145-196.
28. Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA (2005) Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 79: 2988-2997.
29. Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP et al (1994) An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol 68: 6605-6618.
30. Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM et al (2008) PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol 82: 9730-9738.